Trial Profile
A phase I trial to evaluate the feasibility and safety of Skeletal muscle-derived autologous stem cell therapy in patients with old myocardial infarction and ischaemic coronary artery disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Mar 2016
Price :
$35
*
At a glance
- Drugs Autologous stem cell therapy (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions; Therapeutic Use
- 03 Mar 2016 New trial record